Workflow
江苏联环药业股份有限公司2025年第一次临时股东会决议公告

Meeting Overview - The first temporary shareholders' meeting of Jiangsu Lianhuan Pharmaceutical Co., Ltd. was held on August 11, 2025, at the company's conference room in Yangzhou [2] - The meeting was legally convened and presided over by Chairman Qian Zhenhua, utilizing a combination of on-site and online voting methods [2][3] Resolutions Passed - The following resolutions were approved during the meeting: 1. Election of Ms. Wu Fang as an independent director [4] 2. Proposal for the company to issue technology innovation bonds [4] - All current directors and supervisors were present during the voting process [4] Legal Verification - The meeting was witnessed by Beijing Zhonglun (Chengdu) Law Firm, confirming that the convening and voting procedures complied with relevant laws and regulations [6] Committee Adjustments - Following the election of a new independent director, adjustments were made to the members of the Audit Committee and the Nomination Committee: 1. Audit Committee: Changed from Zhang Bin (convener), Chen Ying, Tu Bin to Zhang Bin (convener), Wu Fang, Tu Bin [9] 2. Nomination Committee: Changed from Hu Yiqiao (convener), Chen Ying, Qian Zhenhua to Hu Yiqiao (convener), Wu Fang, Qian Zhenhua [9]